Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

WellBridge Surgical Celebrates Dual Achievement: ACHC Accreditation and 2025 Best Places to Work Honor
Healthcare & PharmaceuticalAwards

WellBridge Surgical Celebrates Dual Achievement: ACHC Accreditation and 2025 Best Places to Work Honor

October 28, 2025 8:00 AM

WellBridge Surgical ("WellBridge") is delighted to announce two major milestones that underscore its unwavering commitment to both clinical excellence and workplace culture: Accreditation by the Accreditation Commission for Health Care (ACHC) for its outpatient surgical facility - a hallmark of quality, safety and operational rigor. Named a winner of the 2025 Indiana Chamber of Commerce "Best Places to Work in Indiana" program, confirming that...

Read more
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
Healthcare & PharmaceuticalCompany Update

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

October 28, 2025 7:45 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company focused on innovative and affordable healthcare solutions, today announced that its wholly owned subsidiary, Nora Pharma Inc., has received approval from Health Canada, the Canadian equivalent to the FDA, for the commercialization of Domperidone, a prescription medication used to relieve nausea and vomiting and to enhance gastrointestinal motility....

Read more
CBD Life Sciences Inc. (OTC: CBDL) Launches Tremendous Energy & Weight-Loss Diet Hemp-Free Gummies
Healthcare & PharmaceuticalCompany Update

CBD Life Sciences Inc. (OTC: CBDL) Launches Tremendous Energy & Weight-Loss Diet Hemp-Free Gummies

October 28, 2025 7:00 AM

CBD Life Sciences Inc. (OTC:CBDL), an emerging leader in wellness innovation and nutraceutical advancement, proudly announces the official launch of its new Energy Boost and Diet & Weight-Loss Hemp-Free Gummies, both formulated with 100 mg vegan, plant-based ingredients. These new releases position CBDL at the intersection of two of the most explosive consumer categories in the global supplement market: energy enhancement and weight management....

Read more
SEAL Analytical Launches New Website Featuring Bioz Badges, Applauds Seamless Integration and Service Excellence
Healthcare & PharmaceuticalPartnerships

SEAL Analytical Launches New Website Featuring Bioz Badges, Applauds Seamless Integration and Service Excellence

October 28, 2025 4:00 AM

Bioz, Inc., a driving force behind AI citation insight platforms, is proud to announce the successful integration of Bioz Badges on SEAL Analytical's newly redesigned website. Known for their innovative wet chemistry automation solutions, including discrete analyzers, continuous flow analyzers, and automated BOD robotics, SEAL Analytical is now enhancing the researcher journey with real-time scientific validation, made possible through a...

Read more
Onco-Innovations Announces Closing of Private Placement
Healthcare & PharmaceuticalCompany Update

Onco-Innovations Announces Closing of Private Placement

October 27, 2025 5:15 PM

Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is pleased to announce that it has closed its previously-announced (see news release dated October 14, 2025) non-brokered private placement (the "Private Placement"), issuing 1,428,570 units of the Company (the "Units") at a price of $1.40 per Unit, for aggregate gross proceeds of $2,000,000. Each Unit consists of one common share (each a...

Read more
UniDoc Closes Fully Subscribed LIFE Offering
Healthcare & PharmaceuticalFinancing

UniDoc Closes Fully Subscribed LIFE Offering

October 27, 2025 5:00 PM

UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company") is pleased to announce that it has closed its previously announced non-brokered private placement LIFE offering (the "Offering") by issuing 10,000,000 units (each a "Unit") at a price of $0.15 per Unit for aggregate gross proceeds of $1,500,000. Each Unit consists of one common share in the capital of the Company and one transferrable common share purchase warrant...

Read more
The Assistance Fund Opens New Program for Immunoglobulin G4-Related Disease
Healthcare & PharmaceuticalCompany Update

The Assistance Fund Opens New Program for Immunoglobulin G4-Related Disease

October 27, 2025 12:00 PM

The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new financial assistance program for people living with immunoglobulin G4-related disease. The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, health insurance premiums, and incidental...

Read more
SoftWriters Welcomes Jeff Hlozek as Chief Revenue Officer
Healthcare & PharmaceuticalCompany Update

SoftWriters Welcomes Jeff Hlozek as Chief Revenue Officer

October 27, 2025 11:15 AM

SoftWriters, the leading provider of pharmacy management software for long-term care (LTC) pharmacies, is pleased to announce the appointment of Jeff Hlozek as its Chief Revenue Officer (CRO). In this newly created role, Hlozek will lead SoftWriters' Sales and Marketing organization and drive strategic growth and alignment across the company's product suite. With more than 25 years of leadership experience spanning healthcare technology,...

Read more
Medical Care Technologies Inc. (OTC PINK:MDCE) Approved as an Official Google Play Developer
Healthcare & PharmaceuticalCompany Update

Medical Care Technologies Inc. (OTC PINK:MDCE) Approved as an Official Google Play Developer

October 27, 2025 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) has been approved as an official developer on the Google Play Store, allowing the company to deploy its AI-powered mobile applications across Android devices around the world. "This approval opens the door for us to bring our technology to millions of Android users around the world," said Marshall Perkins, CEO. "We look forward to launching our upcoming app and expanding MDCE's reach through the...

Read more
Apex Health Names Ruth Krystopolski as Executive Vice President and Chief Operating Officer
Healthcare & PharmaceuticalCompany Update

Apex Health Names Ruth Krystopolski as Executive Vice President and Chief Operating Officer

October 27, 2025 9:00 AM

Apex Health, a tech-enabled management services organization (MSO) that enhances the enterprise value of health systems, today announced the appointment of Ruth Krystopolski, MBA, as Executive Vice President and Chief Operating Officer. In this new role, Krystopolski will oversee enterprise operations and execution across Apex's growing health system partnerships. Krystopolski brings more than 30 years of executive leadership experience across...

Read more
NanoViricides to Present at the PODD 2025 Conference in Boston on October 27
Healthcare & PharmaceuticalConferences

NanoViricides to Present at the PODD 2025 Conference in Boston on October 27

October 27, 2025 8:45 AM

NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be presenting on Monday, October 27th, at 03:00pm at the PODD 2025 Conference in Boston, MA. Event Information: Event NanoViricides Presentation at the PODD 2025, Boston, MA Track 5A Date Monday, October 27, 2025 Time 03:00 pm Location St. George, ABC, at...

Read more
Stemtech Corporation - Stemtech Healthsciences India Pvt Ltd Announces Strategy for Market Entry
Healthcare & PharmaceuticalCompany Update

Stemtech Corporation - Stemtech Healthsciences India Pvt Ltd Announces Strategy for Market Entry

October 27, 2025 8:30 AM

"STEMTECH CORPORATION", the global leader and pioneer in stem cell nutrition and Innoventure Dynamic LLC of India announced on October 23, 2025, a dynamic joint venture, creating Stemtech HealthSciences India Pvt Ltd, a subsidiary of Stemtech Corporation, a Nevada company (OTCQB:STEK). The India Market Stemtech Corporation Chairman & CEO, Charles S. Arnold, states "STEMTECH HEALTHSCIENCES INDIA PVT LTD (SHIPL) is dedicated to bringing...

Read more
Protagonist Announces New Icotrokinra Data in Ulcerative Colitis and Plaque Psoriasis Presented at Two Recent Medical Conferences
Healthcare & PharmaceuticalCompany Update

Protagonist Announces New Icotrokinra Data in Ulcerative Colitis and Plaque Psoriasis Presented at Two Recent Medical Conferences

October 27, 2025 7:35 AM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced new data from two studies of icotrokinra, a first-in-class investigational targeted oral peptide that precisely blocks the IL-23 receptor, presented at two recent medical conferences. Week 28 data from the Phase 2b ANTHEM-UC study of icotrokinra will be presented at the 2025 American College of Gastroenterology Annual Scientific Meeting (ACG), demonstrating sustained...

Read more
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025
Healthcare & PharmaceuticalEarnings

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025

October 27, 2025 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2025 ended September 30, 2025, after the market closes on Thursday, November 6, 2025, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time. To access the conference call, dial toll-free 877-407-0989, for international calls, dial 201-389-0921, ten minutes before the conference. The call can...

Read more
Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb
Healthcare & PharmaceuticalCompany Update

Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb

October 27, 2025 2:50 AM

Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) today announced that the Company has received a payment of US$ 25 m from Bristol Myers Squibb (NYSE: BMY) for scientific progress achieved within their strategic neuroscience partnership. The payment will advance further research and the partners' joint pipeline of programs aimed at tackling neurogenerative diseases. Launched in...

Read more
EXPOSÉ: DEA's Marijuana Licensing Scheme Exposed - MMJ BioPharma's Case Reveals DEA Contradiction Blocking FDA Approved Cannabis Medicine
Healthcare & PharmaceuticalCompany Update

EXPOSÉ: DEA's Marijuana Licensing Scheme Exposed - MMJ BioPharma's Case Reveals DEA Contradiction Blocking FDA Approved Cannabis Medicine

October 26, 2025 2:12 PM

A recently disclosed memorandum of understanding between the DEA and a registered marijuana cultivator has revealed the DEA fatal flaw at the heart of America's cannabis research policy - one that proves MMJ BioPharma Cultivation's case and exposes why legitimate science has been paralyzed for nearly a decade. The Bureaucratic Catch-22 Under the terms of the DEA's own memorandum, licensees are required to perform highly restricted tasks:...

Read more
ASCP Foundation Unveils
Healthcare & PharmaceuticalCompany Update

ASCP Foundation Unveils "The Spirits of Medication Management" - a Legacy Gift to Improve Lives Through Pharmacy

October 25, 2025 11:00 AM

The ASCP Foundation proudly announces The Spirits of Medication Management, an endowed initiative made possible through a generous contribution dedicated to improving the lives of all patients through pharmacist-driven medication management, public awareness, leadership, and systems change. This lasting gift supports efforts to reduce polypharmacy, advance safe medication use, and celebrate the expertise and compassion at the heart of pharmacy....

Read more
GLPro Review (Urgent Report) Blood Sugar Support Gains Attention as Experts Raise Alarms Over Metabolic Wellness
Healthcare & PharmaceuticalAdvertorial

GLPro Review (Urgent Report) Blood Sugar Support Gains Attention as Experts Raise Alarms Over Metabolic Wellness

October 25, 2025 7:40 AM

Metabolic health is undergoing a revolution. For decades, blood sugar support meant single-ingredient fixes or generic advice. But in 2025, the focus has shifted to the gut-metabolic axis, where microbial diversity, gut barrier strength, and inflammation directly influence how the body manages glucose, appetite, and energy. This is where GLPro has emerged as the First Natural Blood Sugar Formula Doctors And Insiders Are Talking About (Verified)....

Read more
GLPro Reviews (ALERT) Doctor Reveals the Truth About This #1 Blood Sugar Formula and Surprising GLPro Side Effects
Healthcare & PharmaceuticalAdvertorial

GLPro Reviews (ALERT) Doctor Reveals the Truth About This #1 Blood Sugar Formula and Surprising GLPro Side Effects

October 24, 2025 6:25 PM

Metabolic health is undergoing a revolution. For decades, blood sugar support meant single-ingredient fixes or generic advice. But in 2025, the focus has shifted to the gut-metabolic axis, where microbial diversity, gut barrier strength, and inflammation directly influence how the body manages glucose, appetite, and energy. This is where GLPro has emerged as the #1 Natural Blood Sugar Formula Doctors And Insiders Are Talking About (Verified)....

Read more
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Healthcare & PharmaceuticalCompany Update

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 24, 2025 4:15 PM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective October 20, 2025, the Company granted 600 restricted stock units (RSUs) to New Employee 1, 600 RSUs to New Employee 2, and 300 RSUs to New Employee 3. The RSUs for New Employees 1, 2 and 3 vest over one year starting from each employee's date of hire. The RSUs for New Employees 1, 2 and 3 were granted as an inducement material to each employee's...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
A blue background with the word access on it
By Jennifer Hammers • June 14, 2026
Compare ACCESS Newswire vs Cision PR Newswire on pricing, features, reach, and reviews — and why companies are making the switch..
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?